Valneva, Serum Call Off Chikungunya Vaccine Deal, What Happens Now?

 
• By Vibha Ravi
  
Valneva And Serum Have Terminated A Chikungunya Vaccine Licensing Deal
Valneva And Serum Have Terminated A Chikungunya Vaccine Licensing Deal (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business